新兴的糖尿病疗法:再生胰腺β细胞
Haojie Zhang1, Yaxin Wei1, Yubo Wang1
1Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, School of Basic Medical Sciences, Henan University, Kaifeng, China.
Tissue engineering. Part B, Reviews
|September 14, 2024
概括
糖尿病 (DM) 影响全球数以百万计的人. 通过干细胞疗法再生胰岛素产生β细胞为治疗这种慢性疾病提供了有希望的未来.
科学领域:
- 内分泌学和再生医学的研究.
- 细胞生物学 细胞生物学
- 糖尿病研究 糖尿病研究
背景情况:
- 糖尿病 (DM) 的全球发病率正在上升,2021年有5.37亿例.
- 恢复β细胞质量和功能对于管理DM,特别是1型DM至关重要.
- 贝塔细胞的自然再生能力有限,需要先进的治疗策略.
研究的目的:
- 审查目前基于细胞的DM治疗方法.
- 讨论贝塔细胞再生中的挑战和潜在解决方案.
- 突出目前在贝塔细胞移植和临床试验方面的持续努力.
主要方法:
- 审查目前的策略,包括内源性β细胞复制,干细胞分化,细胞重编程和有机体生成.
- 对每个方法的挑战和建议解决方案的分析.
- 对正在进行的β细胞或小岛移植的临床试验进行审查.
主要成果:
- 多种基于细胞的策略正在探索DM治疗.
- 在实现可持续和功能性β细胞替代方面,仍然存在重大挑战.
- 目前正在进行的研究和临床试验旨在优化这些疗法.
结论:
- 基于细胞的疗法对产生可移植的功能β细胞的可持续来源充满希望.
- 这些方法是开发未来DM治疗方法的基础.
- 优化β细胞再生和移植是推动DM护理的关键.
相关概念视频
Insulin: Biosynthesis, Chemistry, and Preparation
365
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
365
Tissue Renewal without Stem Cells
1.7K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
1.7K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Glucagon-like Receptor Agonists
306
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
306
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.2K


